It is hoped that, by making this information widely available, this may help the global response to the crisis by enabling healthcare systems around the world to provide respiratory support for patients with Covid-19.
Governments, relevant industry manufacturers, academics and health experts will be able to request access to the designs to ensure quality control over the manufacture. These would also have to meet regulatory approval in the relevant country.
The UCL-Ventura has now undergone patient evaluations at UCLH and across sister hospitals in the London area. After a UK Government order for up to 10,000, the devices are being produced at a rate of up to 1,000 a day at the HPP technology centre in Brixworth, Northamptonshire. Currently, 40 machines that would normally produce F1 pistons and turbochargers are being used for production of the CPAP devices, and the entire Brixworth facility has been repurposed to meet this demand.
Professor Rebecca Shipley, Director of UCL Institute of Healthcare Engineering, said: “These life-saving devices are relatively simple to manufacture and can be produced quickly. We hope that, by making the blueprints publicly available, they can be used to improve the resilience of healthcare systems preparing for the Covid-19 pandemic globally. My thanks goes to the brilliant engineers, business managers and team at UCLB who have come together and made this happen at a pace that would be considered unimaginable under normal circumstances.”